Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers
Journal of Antimicrobial Chemotherapy2011Vol. 66(7), pp. 1567–1572
Citations Over TimeTop 10% of 2011 papers
Parul Patel, Ivy Song, Julie Borland, A. Patel, Yu Lou, S. Chen, Teruaki Wajima, Amanda Peppercorn, S. S. Min, Stephen C. Piscitelli
Abstract
S/GSK1349572 can be taken with proton pump inhibitors and MVIs without dose adjustment but should be administered 2 h before or 6 h after antacids.
Related Papers
- → Effect of an orally administered antacid agent containing aluminum hydroxide and magnesium hydroxide on abomasal luminal pH in clinically normal milk-fed calves(2002)26 cited
- → Addition of oxethazaine to a standard antacid in treatment of duodenal ulcer(1972)8 cited
- → Comparison of two marketed effervescent fast relief formulations for antacid activity-an in vitro study(2021)1 cited
- → A Study of Antacid Buffers. II. Prolonged neutralization(1948)10 cited